APA (7th ed.) Citation

AG, T., WB, C., DT, F., SB, M., & SC, S. (2012). Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state. Molecular pharmaceutics, 9(12), 3526. https://doi.org/10.1021/mp3003607

Chicago Style (17th ed.) Citation

AG, Thombre, Caldwell WB, Friesen DT, McCray SB, and Sutton SC. "Solid Nanocrystalline Dispersions of Ziprasidone with Enhanced Bioavailability in the Fasted State." Molecular Pharmaceutics 9, no. 12 (2012): 3526. https://doi.org/10.1021/mp3003607.

MLA (9th ed.) Citation

AG, Thombre, et al. "Solid Nanocrystalline Dispersions of Ziprasidone with Enhanced Bioavailability in the Fasted State." Molecular Pharmaceutics, vol. 9, no. 12, 2012, p. 3526, https://doi.org/10.1021/mp3003607.